Hospira to Present at the Morgan Stanley 2008 Healthcare Conference on September...

Hospira to Present at the Morgan Stanley 2008 Healthcare Conference on
September 9

LAKE FOREST, Ill., Aug. 27 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE: HSP), a global specialty pharmaceutical and medication delivery
company, today announced that Christopher B. Begley, chairman and chief
executive officer, will make a formal presentation at the Morgan Stanley
2008 Healthcare Conference on Tuesday, Sept. 9, 2008, at the Grand Hyatt in
New York City.
The presentation is scheduled to begin at 9:45 a.m. Eastern time on
Tuesday, Sept. 9, 2008. It will be available to all interested parties through
a live audiocast accessible via the investor relations section of Hospira's
Web site at www.hospirainvestor.com. Listeners should log on approximately
10 minutes in advance to ensure proper computer setup to receive the
audiocast. The slides accompanying the presentation will be available on the
Hospira Web site. A replay of the webcast will be available on the Hospira Web
site approximately 24 hours after the live presentation.
About Hospira
Hospira, Inc. is a global specialty pharmaceutical and medication delivery
company dedicated to Advancing Wellness(TM). As the world leader in specialty
generic injectable pharmaceuticals, Hospira offers one of the broadest
portfolios of generic acute-care and oncology injectables, as well as
integrated infusion therapy and medication management solutions. Through its
products, Hospira helps improve the safety, cost and productivity of patient
care. The company is headquartered in Lake Forest, Ill., and has more than
14,000 employees. Learn more at www.hospira.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO)
SOURCE Hospira, Inc.

Media, Stacey Eisen, +1-224-212-2276, or Financial Community, Karen King,
+1-224-212-2711, both of Hospira, Inc.